Developer docs
API playgroundTry for free, no card

Search company profiles

SCRI Oncology Partners

Full company profile

uuid0042tpr

Namestring
SCRI Oncology Partners
Legal namestring
SCRI Oncology Partners
Company typeenum
Private
Founded yearstring
-
Descriptiontext

SCRI Oncology Partners is a privately held, community-based cancer treatment center headquartered in Nashville, Tennessee, with 25 employees and a medical staff of 25+ physicians and advanced practice providers. The practice is affiliated with the Sarah Cannon Research Institute (SCRI) and operates as a member of The US Oncology Network, giving it access to one of the largest community oncology infrastructures in the United States. It is the only oncology provider in the Nashville market offering Phase I through Phase IV clinical trials, and its providers have collectively contributed to over 170 research journals, signaling active participation in oncology research and trial enrollment across multiple tumor types including breast, hematologic, thoracic, and gastrointestinal cancers.

On September 24, 2025, the practice launched a dedicated Center for Breast Health and High-Risk Clinic, formalizing breast cancer screening, treatment, and risk assessment under a single service line. The practice has also recently expanded its medical staff with additions in hematology and breast surgical oncology and has integrated digital patient-engagement (Navigating Care) and revenue-cycle (GoToBilling) platforms to support operational scaling.

The business model is a fee-for-service clinical-care model: revenue is generated from reimbursement for office visits, infusion services, imaging, surgical procedures, and clinical trial enrollment, billed to commercial insurance, Medicare, Medicaid, and self-pay patients across Middle Tennessee and adjacent states. The go-to-market motion is primarily physician referral–driven, supplemented by community outreach and event-based patient engagement, and is reinforced by the brand recognition of the Sarah Cannon and US Oncology Network affiliations.

Short descriptiontext

SCRI Oncology Partners is a private, Nashville-based community cancer treatment center and the only Nashville provider offering Phase I–IV clinical trials, serving patients across Middle Tennessee through its affiliation with Sarah Cannon Research Institute and The US Oncology Network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNashville, United States
HQ citystring
Nashville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology care services, cancer treatment center, clinical trials, precision oncology, immunotherapy treatments
Industry3 codes
PRIMARYHLAKAFAB
Medical Oncology
SECONDARYHLAKAFAG
Surgical Oncology
SECONDARYHLAKAFAF
Gynecologic Oncology
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Oncology Care Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Oncology Care Services
TypeSubscription Recurring
Description

Direct patient care services including chemotherapy, immunotherapy, targeted therapy, hormone therapy, radiation therapy, and surgical services for cancer treatment. Revenue generated through medical services billed to patients and insurance providers.

cancercarescri.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Pricing details1 tier
1Healthcare services with variable costs based on treatment plan
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing not publicly disclosed - quote-based consultation required. Financial counseling available for patients.

cancercarescri.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Center for Breast Health
Description

A specialized center focused on breast health, launched in September 2025, offering comprehensive breast cancer care and a High-Risk Clinic.

cancercarescri.com
Core offering1 text field

SCRI Oncology Partners is a Nashville-based cancer treatment center delivering comprehensive oncology care including chemotherapy, immunotherapy, targeted therapy, hormone therapy, bispecific therapy, radiation therapy, and breast cancer surgery. The center offers diagnostic services such as next-generation sequencing (NGS) for biomarker testing and genetic testing, alongside supportive services including palliative care, financial counseling, and survivorship programs. Through affiliation with Sarah Cannon Research Institute, it provides access to Phase I-IV clinical trials.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Only Phase I-IV clinical trial provider in Nashville
+1 more record
Product overview1 text field

SCRI Oncology Partners is a Nashville-based cancer treatment center offering a unified platform of integrated oncology services. The core treatment portfolio includes chemotherapy, immunotherapy, targeted therapy, hormone therapy, bispecific therapy, and radiation therapy, complemented by diagnostic services such as next-generation sequencing (NGS) for biomarker testing and genetic testing. The organization operates specialty centers including the Center for Breast Health with High-Risk Breast Clinic, and provides supportive care services including palliative care, financial counseling, survivorship programs, and caregiver resources. Through its affiliation with Sarah Cannon Research Institute, SCRI Oncology Partners offers access to Phase I-IV clinical trials—the only organization in Nashville providing all phases of clinical trials. The unified offering combines cutting-edge treatments with compassionate, personalized patient care.

Product and service16 records
1Chemotherapy
CategoryCore Treatment
2Immunotherapy
CategoryCore Treatment
3Targeted Therapy
CategoryCore Treatment
4Hormone Therapy
CategoryCore Treatment
5Bispecific Therapy
CategoryCore Treatment
6Radiation Therapy
CategoryCore Treatment
7Breast Cancer Surgery
CategorySurgical Service
8Next-Generation Sequencing (NGS)
CategoryDiagnostic Service
9Genetic Testing
CategoryDiagnostic Service
10Clinical Trials
CategoryResearch Program
11Center for Breast Health
CategorySpecialty Center
12High-Risk Breast Clinic
CategorySpecialty Clinic
13Palliative Care Services
CategorySupportive Care
14Financial Counseling
CategorySupportive Care
15Survivorship Program
CategorySupportive Care
16Second Opinion Services
CategoryConsultation Service
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Sarah Cannon Research Institute (SCRI)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SCRI Oncology Partners conducts clinical trials through affiliation with Sarah Cannon Research Institute, one of the world's leading oncology research organizations. Since its inception more than 30 years ago, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the U.S. Food and Drug Administration (FDA) today. This partnership provides patients direct access to the latest clinical trials and innovative treatments.

cancercarescri.com
2The US Oncology Network
Strategic tierCoreTypeStrategic or Co-development Partner
Description

SCRI Oncology is a member of The US Oncology Network, a national network of over 2,600 independent physicians dedicated to providing collaborative localized care to enable better support for cancer patients. Led by physicians, the network focuses on using the latest technology and best practices to ensure integrated care is available and accessible to more people in their local communities, working with physicians, payers, hospitals and academic institutions across the United States.

cancercarescri.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Tennessee Oncology
TypeDirect peer
Description

Largest independent community oncology practice in Tennessee, headquartered in Nashville; directly competes with SCRI Oncology Partners for the same patient population, referring physicians, and clinical trial slots across Middle Tennessee.

2Florida Cancer Specialists & Research Institute
TypeDirect peer
Description

Large community oncology practice with deep Phase I-IV clinical trial infrastructure and Sarah Cannon/US Oncology Network affiliations; operates with a similar scale, multispecialty physician mix, and community-based trial model outside of Florida.

3OneOncology
TypeDirect peer
Description

Network of independent community oncology practices; a parallel platform to US Oncology Network that competes for the same independent practice acquisition and partnership pipeline.

4Sarah Cannon Research Institute
TypeBroad incumbent
Description

One of the world's leading oncology research organizations and the research partner of SCRI Oncology Partners; conducts Phase I-IV trials across a national network and is the upstream provider of trial access that anchors SCRI Oncology Partners' differentiation.

5Vanderbilt-Ingram Cancer Center
TypeRegional player
Description

NCI-designated academic cancer center in Nashville; competes for high-acuity and complex trial patients, second opinions, and specialist referrals in the same primary geography.

6START (Clinical Research)
TypeDirect peer
Description

Global Phase I-focused oncology research network; competes for early-phase drug development trial placements and biopharma sponsor relationships with the same investigator pool.

7Maryland Oncology Hematology
TypeDirect peer
Description

US Oncology Network-affiliated community oncology practice operating under the same parent network and partnership template as SCRI Oncology Partners.

8City of Hope
TypeBroad incumbent
Description

Large NCI-designated cancer center expanding into community oncology through acquisitions; represents the academic-system capital that may eventually compete for community trial sites in the Southeast.

9Willamette Valley Cancer Institute
TypeDirect peer
Description

US Oncology Network-affiliated community oncology practice; closely comparable operating model with multi-specialty medical oncology, clinical trials, and supportive care services.

10MD Anderson Cancer Center
TypeBroad incumbent
Description

Premier global academic cancer center; competes for the highest-acuity second opinions, complex trial patients, and sets the clinical benchmark that community research practices are measured against.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles27 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SCRI Oncology Partners

Oncology Care Servicescancercarescri.com

SCRI Oncology Partners is a private, Nashville-based community cancer treatment center and the only Nashville provider offering Phase I–IV clinical trials, serving patients across Middle Tennessee through its affiliation with Sarah Cannon Research Institute and The US Oncology Network.

What SCRI Oncology Partners does

SCRI Oncology Partners is a privately held, community-based cancer treatment center headquartered in Nashville, Tennessee, with 25 employees and a medical staff of 25+ physicians and advanced practice providers. The practice is affiliated with the Sarah Cannon Research Institute (SCRI) and operates as a member of The US Oncology Network, giving it access to one of the largest community oncology infrastructures in the United States. It is the only oncology provider in the Nashville market offering Phase I through Phase IV clinical trials, and its providers have collectively contributed to over 170 research journals, signaling active participation in oncology research and trial enrollment across multiple tumor types including breast, hematologic, thoracic, and gastrointestinal cancers.

On September 24, 2025, the practice launched a dedicated Center for Breast Health and High-Risk Clinic, formalizing breast cancer screening, treatment, and risk assessment under a single service line. The practice has also recently expanded its medical staff with additions in hematology and breast surgical oncology and has integrated digital patient-engagement (Navigating Care) and revenue-cycle (GoToBilling) platforms to support operational scaling.

The business model is a fee-for-service clinical-care model: revenue is generated from reimbursement for office visits, infusion services, imaging, surgical procedures, and clinical trial enrollment, billed to commercial insurance, Medicare, Medicaid, and self-pay patients across Middle Tennessee and adjacent states. The go-to-market motion is primarily physician referral–driven, supplemented by community outreach and event-based patient engagement, and is reinforced by the brand recognition of the Sarah Cannon and US Oncology Network affiliations.

SCRI Oncology Partners firmographics

Firmographics
Name
SCRI Oncology Partners
Legal name
SCRI Oncology Partners
Website
https://cancercarescri.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
SCRI Oncology Partners is a private, Nashville-based community cancer treatment center and the only Nashville provider offering Phase I–IV clinical trials, serving patients across Middle Tennessee through its affiliation with Sarah Cannon Research Institute and The US Oncology Network.
Ownership category
akta.pro rank

SCRI Oncology Partners industry classification

Industry
Product category
Oncology Care Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAKAFAB
Medical Oncology
SECONDARYHLAKAFAG
Surgical Oncology
SECONDARYHLAKAFAF
Gynecologic Oncology

Keywords

  • Oncology care services
  • Cancer treatment center
  • Clinical trials
  • Precision oncology
  • Immunotherapy treatments

Where SCRI Oncology Partners is headquartered

Location

Headquarters

HQ city
Nashville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SCRI Oncology Partners business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

  1. Oncology Care Services: Direct patient care services including chemotherapy, immunotherapy, targeted therapy, hormone therapy, radiation therapy, and surgical services for cancer treatment. Revenue generated through medical services billed to patients and insurance providers.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractHealthcare services with variable costs based on treatment plan

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

SCRI Oncology Partners product offering

Product offering

Core offering

SCRI Oncology Partners is a Nashville-based cancer treatment center delivering comprehensive oncology care including chemotherapy, immunotherapy, targeted therapy, hormone therapy, bispecific therapy, radiation therapy, and breast cancer surgery. The center offers diagnostic services such as next-generation sequencing (NGS) for biomarker testing and genetic testing, alongside supportive services including palliative care, financial counseling, and survivorship programs. Through affiliation with Sarah Cannon Research Institute, it provides access to Phase I-IV clinical trials.

Product overview

SCRI Oncology Partners is a Nashville-based cancer treatment center offering a unified platform of integrated oncology services. The core treatment portfolio includes chemotherapy, immunotherapy, targeted therapy, hormone therapy, bispecific therapy, and radiation therapy, complemented by diagnostic services such as next-generation sequencing (NGS) for biomarker testing and genetic testing. The organization operates specialty centers including the Center for Breast Health with High-Risk Breast Clinic, and provides supportive care services including palliative care, financial counseling, survivorship programs, and caregiver resources. Through its affiliation with Sarah Cannon Research Institute, SCRI Oncology Partners offers access to Phase I-IV clinical trials—the only organization in Nashville providing all phases of clinical trials. The unified offering combines cutting-edge treatments with compassionate, personalized patient care.

Differentiator

Problem solved

Functional benefit

Brands

  • Center for Breast Health: A specialized center focused on breast health, launched in September 2025, offering comprehensive breast cancer care and a High-Risk Clinic.

Products and services

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Hormone Therapy
  • Bispecific Therapy
  • Radiation Therapy
  • Breast Cancer Surgery
  • Next-Generation Sequencing (NGS)
  • Genetic Testing
  • Clinical Trials
  • Center for Breast Health
  • High-Risk Breast Clinic
  • Palliative Care Services
  • Financial Counseling
  • Survivorship Program
  • Second Opinion Services

Quantifiable outcome

  • Only Phase I-IV clinical trial provider in Nashville
  • +1 more outcomes

Companies that use SCRI Oncology Partners

Customer profile

Segments3 records

Ideal customer profiles2 records

SCRI Oncology Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

SCRI Oncology Partners partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Sarah Cannon Research Institute (SCRI)coreStrategic or Co-development PartnerSCRI Oncology Partners conducts clinical trials through affiliation with Sarah Cannon Research Institute, one of the world's leading oncology research organizations. Since its inception more than 30 years ago, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the U.S. Food and Drug Administration (FDA) today. This partnership provides patients direct access to the latest clinical trials and innovative treatments.
  • The US Oncology NetworkcoreStrategic or Co-development PartnerSCRI Oncology is a member of The US Oncology Network, a national network of over 2,600 independent physicians dedicated to providing collaborative localized care to enable better support for cancer patients. Led by physicians, the network focuses on using the latest technology and best practices to ensure integrated care is available and accessible to more people in their local communities, working with physicians, payers, hospitals and academic institutions across the United States.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

SCRI Oncology Partners competitors and assessment

Company assessment

Direct peers

  • Tennessee Oncology: Largest independent community oncology practice in Tennessee, headquartered in Nashville; directly competes with SCRI Oncology Partners for the same patient population, referring physicians, and clinical trial slots across Middle Tennessee.
  • Florida Cancer Specialists & Research Institute: Large community oncology practice with deep Phase I-IV clinical trial infrastructure and Sarah Cannon/US Oncology Network affiliations; operates with a similar scale, multispecialty physician mix, and community-based trial model outside of Florida.
  • OneOncology: Network of independent community oncology practices; a parallel platform to US Oncology Network that competes for the same independent practice acquisition and partnership pipeline.
  • START (Clinical Research): Global Phase I-focused oncology research network; competes for early-phase drug development trial placements and biopharma sponsor relationships with the same investigator pool.
  • Maryland Oncology Hematology: US Oncology Network-affiliated community oncology practice operating under the same parent network and partnership template as SCRI Oncology Partners.
  • Willamette Valley Cancer Institute: US Oncology Network-affiliated community oncology practice; closely comparable operating model with multi-specialty medical oncology, clinical trials, and supportive care services.

Broad incumbents

  • Sarah Cannon Research Institute: One of the world's leading oncology research organizations and the research partner of SCRI Oncology Partners; conducts Phase I-IV trials across a national network and is the upstream provider of trial access that anchors SCRI Oncology Partners' differentiation.
  • City of Hope: Large NCI-designated cancer center expanding into community oncology through acquisitions; represents the academic-system capital that may eventually compete for community trial sites in the Southeast.
  • MD Anderson Cancer Center: Premier global academic cancer center; competes for the highest-acuity second opinions, complex trial patients, and sets the clinical benchmark that community research practices are measured against.

Regional players

  • Vanderbilt-Ingram Cancer Center: NCI-designated academic cancer center in Nashville; competes for high-acuity and complex trial patients, second opinions, and specialist referrals in the same primary geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

SCRI Oncology Partners social profiles

Digital presence

SCRI Oncology Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SCRI Oncology Partners leadership team

Management profile

Number of profiles

Profiles27 records

SCRI Oncology Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SCRI Oncology Partners M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCRI Oncology Partners

What does SCRI Oncology Partners do?

SCRI Oncology Partners is a Nashville-based cancer treatment center delivering comprehensive oncology care including chemotherapy, immunotherapy, targeted therapy, hormone therapy, bispecific therapy, radiation therapy, and breast cancer surgery. The center offers diagnostic services such as next-generation sequencing (NGS) for biomarker testing and genetic testing, alongside supportive services including palliative care, financial counseling, and survivorship programs. Through affiliation with Sarah Cannon Research Institute, it provides access to Phase I-IV clinical trials.

Is SCRI Oncology Partners a public or private company?

SCRI Oncology Partners is a private company. It is classified as unknown and is currently operating.

When was SCRI Oncology Partners founded?

SCRI Oncology Partners was founded in -1. It employs 11 to 50 people.

Where is SCRI Oncology Partners based?

SCRI Oncology Partners is headquartered in Nashville, United States, in the North America region.

How does SCRI Oncology Partners make money?

One revenue line is on record: oncology Care Services.

Who are SCRI Oncology Partners's main competitors?

Direct peers on record are Tennessee Oncology, Florida Cancer Specialists & Research Institute, OneOncology, START (Clinical Research), Maryland Oncology Hematology and Willamette Valley Cancer Institute. Broad incumbents are Sarah Cannon Research Institute, City of Hope and MD Anderson Cancer Center. Vanderbilt-Ingram Cancer Center is listed as a regional player.

Does SCRI Oncology Partners have an API?

No public API is recorded for SCRI Oncology Partners.

What industry is SCRI Oncology Partners in?

SCRI Oncology Partners's product category is Oncology Care Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAKAFAG, Surgical Oncology. Its NAICS code is 5417 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals